PTGS2 and lung carcinoma: Various compounds, including COX-2 and histone deacetylation inhibitors, have been identified to induce 15-PGDH as part of their chemo-preventative activities (13,14); however, the clinical studies of 15-PGDH on lung cancer are limited.